227 related articles for article (PubMed ID: 10811567)
1. Metallothionein isoform 3 as a potential biomarker for human bladder cancer.
Sens MA; Somji S; Lamm DL; Garrett SH; Slovinsky F; Todd JH; Sens DA
Environ Health Perspect; 2000 May; 108(5):413-8. PubMed ID: 10811567
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein isoform 1 and 2 gene expression in the human bladder: evidence for upregulation of MT-1X mRNA in bladder cancer.
Somji S; Sens MA; Lamm DL; Garrett SH; Sens DA
Cancer Detect Prev; 2001; 25(1):62-75. PubMed ID: 11270423
[TBL] [Abstract][Full Text] [Related]
3. Metallothionein-1 and -2 expression in cadmium- or arsenic-derived human malignant urothelial cells and tumor heterotransplants and as a prognostic indicator in human bladder cancer.
Zhou XD; Sens DA; Sens MA; Namburi VB; Singh RK; Garrett SH; Somji S
Toxicol Sci; 2006 Jun; 91(2):467-75. PubMed ID: 16565513
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of metallothionein isoform 3 protein in tumor heterotransplants derived from As+3- and Cd+2-transformed human urothelial cells.
Zhou XD; Sens MA; Garrett SH; Somji S; Park S; Gurel V; Sens DA
Toxicol Sci; 2006 Oct; 93(2):322-30. PubMed ID: 16854967
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein isoform 1 and 2 gene expression in the human prostate: downregulation of MT-1X in advanced prostate cancer.
Garrett SH; Sens MA; Shukla D; Flores L; Somji S; Todd JH; Sens DA
Prostate; 2000 May; 43(2):125-35. PubMed ID: 10754528
[TBL] [Abstract][Full Text] [Related]
6. In vivo gene expression profile analysis of metallothionein in renal cell carcinoma.
Nguyen A; Jing Z; Mahoney PS; Davis R; Sikka SC; Agrawal KC; Abdel-Mageed AB
Cancer Lett; 2000 Nov; 160(2):133-40. PubMed ID: 11053642
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of EZH2, a polycomb group protein, in bladder carcinoma.
Arisan S; Buyuktuncer ED; Palavan-Unsal N; Caşkurlu T; Cakir OO; Ergenekon E
Urol Int; 2005; 75(3):252-7. PubMed ID: 16215315
[TBL] [Abstract][Full Text] [Related]
8. KIAA1096, a gene on chromosome 1q, is amplified and overexpressed in bladder cancer.
Huang WC; Taylor S; Nguyen TB; Tomaszewski JE; Libertino JA; Malkowicz SB; McGarvey TW
DNA Cell Biol; 2002 Oct; 21(10):707-15. PubMed ID: 12443540
[TBL] [Abstract][Full Text] [Related]
9. Metallothionein 2A expression is associated with cell proliferation in breast cancer.
Jin R; Chow VT; Tan PH; Dheen ST; Duan W; Bay BH
Carcinogenesis; 2002 Jan; 23(1):81-6. PubMed ID: 11756227
[TBL] [Abstract][Full Text] [Related]
10. Expression analysis of VEGF-A and VEGF-B: relationship with clinicopathological parameters in bladder cancer.
Fauconnet S; Bernardini S; Lascombe I; Boiteux G; Clairotte A; Monnien F; Chabannes E; Bittard H
Oncol Rep; 2009 Jun; 21(6):1495-504. PubMed ID: 19424629
[TBL] [Abstract][Full Text] [Related]
11. Correlation between messenger RNA expression and protein expression of immune checkpoint-associated molecules in bladder urothelial carcinoma: A retrospective study.
Le Goux C; Damotte D; Vacher S; Sibony M; Delongchamps NB; Schnitzler A; Terris B; Zerbib M; Bieche I; Pignot G
Urol Oncol; 2017 May; 35(5):257-263. PubMed ID: 28291636
[TBL] [Abstract][Full Text] [Related]
12. Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.
Junttila TT; Laato M; Vahlberg T; Söderström KO; Visakorpi T; Isola J; Elenius K
Clin Cancer Res; 2003 Nov; 9(14):5346-57. PubMed ID: 14614020
[TBL] [Abstract][Full Text] [Related]
13. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
Zhan J; Tang XD
Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
[TBL] [Abstract][Full Text] [Related]
14. Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells.
Yamasaki M; Nomura T; Sato F; Mimata H
Oncol Rep; 2007 Nov; 18(5):1145-53. PubMed ID: 17914565
[TBL] [Abstract][Full Text] [Related]
15. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
[TBL] [Abstract][Full Text] [Related]
16. Frequent expression of zinc-finger protein ZNF165 in human urinary bladder transitional cell carcinoma.
Singh PK; Srivastava AK; Dalela D; Rath SK; Goel MM; Bhatt ML
Immunobiology; 2015 Jan; 220(1):68-73. PubMed ID: 25214475
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of metallothionein 1 and 2 isoforms in breast cancer lines with different invasive potential: identification of a novel nonsilent metallothionein-1H mutant variant.
Tai SK; Tan OJ; Chow VT; Jin R; Jones JL; Tan PH; Jayasurya A; Bay BH
Am J Pathol; 2003 Nov; 163(5):2009-19. PubMed ID: 14578200
[TBL] [Abstract][Full Text] [Related]
18. Metallothionein 1 isoform gene expression induced by cadmium in human peripheral blood lymphocytes.
Chang XL; Jin TY; Zhou YF
Biomed Environ Sci; 2006 Apr; 19(2):104-9. PubMed ID: 16827180
[TBL] [Abstract][Full Text] [Related]
19. Metallothionein gene expression in bladder cancer exposed to cisplatin.
Wood DP; Klein E; Fair WR; Chaganti RS
Mod Pathol; 1993 Jan; 6(1):33-5. PubMed ID: 8426855
[TBL] [Abstract][Full Text] [Related]
20. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]